Skip to content

Protein Therapeutics

Evox’s proprietary protein engineering technology enables loading of protein therapeutics and tissue targeting moieties onto the surfaces of exosomes, which allows targeting and display of therapeutic proteins to an organ of interest.

Additionally, Evox protein engineering strategies comprise methods for loading the inside of exosomes with various types of drug cargo, notably therapeutic proteins, and nucleic acids. This modification of the protein composition of exosomes is key to developing potent therapeutics harnessing both the native effects of exosomes and the specificity and affinity of conventional biologics, such as monoclonal antibodies and siRNAs.

 

 

We use cookies to give you the best experience of using this website. By continuing to use this site, you accept our use of cookies. Please read our Cookie Policy for more information.